GL1X · GenesisL1 explorer

UniProt Q00534

Cyclin-dependent kinase 6 (Q00534)

Cyclin-dependent kinase 6 (UniProt Q00534), EC 2.7.11.22: 36 experimental structures and 1 predicted model on GenesisL1, 6 ligands bound, 9 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q00534
Protein
Cyclin-dependent kinase 6
EC
2.7.11.22
Experimental structures
36
Predicted models
1
Ligands
6
Pockets
9 · 5 records with a druggable one

Structures

37 records of Q00534 in the MolNFT archive: 36 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1BI7Mechanism of G1 cyclin dependent kinase inhibition from the structure of the CDK6-P16INK4A tumor…x-ray diffractionA——
1BI7Mechanism of G1 cyclin dependent kinase inhibition from the structure of the CDK6-P16INK4A tumor…x-ray diffractionA——
1BI8Mechanism of G1 cyclin dependent kinase inhibition from the structures CDK6-P19INK4D inhibitor…x-ray diffractionA, C——
1BI8Mechanism of G1 cyclin dependent kinase inhibition from the structures CDK6-P19INK4D inhibitor…x-ray diffractionA, C——
1BLXP19INK4D/CDK6 complexx-ray diffractionA——
1BLXP19INK4D/CDK6 complexx-ray diffractionA——
1G3NStructure of a P18(INK4C)-CDK6-K-cyclin ternary complexx-ray diffractionA, E——
1G3NStructure of a P18(INK4C)-CDK6-K-cyclin ternary complexx-ray diffractionA, E——
1JOWCrystal structure of a complex of human CDK6 and a viral cyclinx-ray diffractionB——
1JOWCrystal structure of a complex of human CDK6 and a viral cyclinx-ray diffractionB——
1XO2Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetinx-ray diffractionB——
1XO2Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetinx-ray diffractionB——
2EUFX-ray structure of human CDK6-Vcyclin in complex with the inhibitor PD0332991x-ray diffractionB——
2EUFX-ray structure of human CDK6-vcyclin in complex with the inhibitor PD0332991x-ray diffractionB——
2F2CX-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanolx-ray diffractionB——
2F2CX-ray structure of human CDK6-vcyclinwith the inhibitor aminopurvalanolx-ray diffractionB——
3NUPCDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
3NUPCDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
3NUXCDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
3NUXCDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
4AUALiganded X-ray crystal structure of cyclin dependent kinase 6 (CDK6)x-ray diffractionA——
4AUALiganded X-ray crystal structure of cyclin dependent kinase 6 (CDK6)x-ray diffractionA——
4EZ5CDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
4EZ5CDK6 (monomeric) in complex with inhibitorx-ray diffractionA——
4TTHCrystal structure of a CDK6/Vcyclin complex with inhibitor boundx-ray diffractionB——
4TTHCrystal structure of a CDK6/VCYCLIN complex with inhibitor boundx-ray diffractionB——
5L2IThe X-ray co-crystal structure of human CDK6 and Palbociclib.x-ray diffractionALQQ1 (best 0.70)
5L2IThe X-ray co-crystal structure of human CDK6 and palbociclib.x-ray diffractionALQQ—
5L2SThe X-ray co-crystal structure of human CDK6 and Abemaciclib.x-ray diffractionA6ZV2 (best 0.62)
5L2SThe X-ray co-crystal structure of human CDK6 and abemaciclib.x-ray diffractionA6ZV—
5L2TThe X-ray co-crystal structure of human CDK6 and Ribociclib.x-ray diffractionA6ZZ2 (best 0.71)
5L2TThe X-ray co-crystal structure of human CDK6 and ribociclib.x-ray diffractionA6ZZ—
6OQLCDK6 in complex with Cpd13 (R)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl…x-ray diffractionAN1A2 (best 0.70)
6OQLCDK6 in complex with CPD13 (R)-5-fluoro-4-(4-methyl-5,6,7,8…x-ray diffractionAN1A—
6OQOCDK6 in complex with CPD24 N-(5-(6-ethyl-2,6-DIAZASPIRO[3.3]HEPTAN-2…x-ray diffractionAN1J—
8I0MStructure of CDK6 in complex with inhibitorx-ray diffractionANJ62 (best 0.67)
Q00534AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 6 (Q00534)predictedA——

Ligands

  • 6ZV · N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amine · in 2 records
  • 6ZZ · 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide · in 2 records
  • LQQ · 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one · in 2 records
  • N1A · 5-fluoro-N-[5-(4-methylpiperazin-1-yl)pyridin-2-yl]-4-[(4R)-4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl]pyrimidin-2-amine · in 2 records
  • N1J · N-[5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl]-5-fluoro-4-[(4R)-4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl]pyrimidin-2-amine · in 1 record
  • NJ6 · 2-[(4-azanylcyclohexyl)amino]-7-cyclopentyl-~{N},~{N}-dimethyl-pyrrolo[2,3-d]pyrimidine-6-carboxamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.